Detalhe da pesquisa
1.
Tocilizumab for severe COVID-19 related illness - A community academic medical center experience.
Cytokine X
; 2(4): 100035, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32895645